Literature DB >> 28383684

Functional variants in DCAF4 associated with lung cancer risk in European populations.

Hongliang Liu1,2, Zhensheng Liu1,2, Yanru Wang1,2, Thomas E Stinchcombe1,2, Kouros Owzar1,3, Younghun Han4, Rayjean J Hung5, Yonathan Brhane5, John McLaughlin6, Paul Brennan7, Heike Bickeböller8, Albert Rosenberger8, Richard S Houlston9, Neil Caporaso10, Maria T Landi10, Irene Brüske11, Angela Risch12, Xifeng Wu13, Yuanqing Ye13, David C Christiani14,15, Christopher I Amos4, Qingyi Wei1,2.   

Abstract

Cullin-RING ubiquitin ligases (CRLs) responsible for substrate specificity of ubiquitination play a key role in cell-cycle control and DNA damage response. In this study, we assessed associations between 16 599 SNPs in 115 CRL genes and lung cancer risk by using summary data of six published genome-wide association studies (GWASs) of 12 160 cases and 16 838 cases of European ancestry. As a result, we identified three independent SNPs in DCAF4 (rs117781739, rs12587742 and rs2240980) associated with lung cancer risk (odds ratio = 0.91, 1.09 and 1.09, respectively; 95% confidence interval = 0.88-0.95, 1.05-1.14 and 1.05-1.13, respectively; and P = 3.99 × 10-6, 4.97 × 10-5 and 1.44 × 10-5, respectively) after multiple comparison correction by a false discovery rate <0.05. Since SNP rs12587742 is located within the promoter region and one CpG island of DCAF4, we further performed in silico functional analyses and found that the rs12587742 variant A allele was associated with an increased mRNA expression (P = 2.20 × 10-16, 1.79 × 10-13 and 0.001 in blood cells, normal lung tissues and tumor tissues of lung squamous carcinoma, respectively) and a decreased methylation status (P = 2.48 × 10-9 and 0.032 in adipose and lung tumor tissues, respectively). Moreover, evidence from differential expression analyses further supported an oncogenic effect of DCAF4 on lung cancer, with higher mRNA levels in both lung squamous carcinoma and adenocarcinoma (P = 4.48 × 10-11 and 1.22 × 10-9, respectively) than in adjacent normal tissues. Taken together, our results suggest that rs12587742 is associated with an increased lung cancer risk, possibly by up-regulating mRNA expression and decreasing methylation status of DCAF4.
© The Author 2017. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28383684      PMCID: PMC6074950          DOI: 10.1093/carcin/bgx033

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  48 in total

Review 1.  E2F1 and telomerase: alliance in the dark side.

Authors:  Marta M Alonso; Juan Fueyo; W K Alfred Yung; Candelaria Gomez-Manzano
Journal:  Cell Cycle       Date:  2006-05-01       Impact factor: 4.534

2.  Genome-wide association scan of tag SNPs identifies a susceptibility locus for lung cancer at 15q25.1.

Authors:  Christopher I Amos; Xifeng Wu; Peter Broderick; Ivan P Gorlov; Jian Gu; Timothy Eisen; Qiong Dong; Qing Zhang; Xiangjun Gu; Jayaram Vijayakrishnan; Kate Sullivan; Athena Matakidou; Yufei Wang; Gordon Mills; Kimberly Doheny; Ya-Yu Tsai; Wei Vivien Chen; Sanjay Shete; Margaret R Spitz; Richard S Houlston
Journal:  Nat Genet       Date:  2008-04-02       Impact factor: 38.330

3.  Regulation of p27 by S-phase kinase-associated protein 2 is associated with aggressiveness in non-small-cell lung cancer.

Authors:  Atsushi Osoegawa; Ichiro Yoshino; Shinji Tanaka; Kenji Sugio; Toshifumi Kameyama; Masafumi Yamaguchi; Yoshihiko Maehara
Journal:  J Clin Oncol       Date:  2004-10-15       Impact factor: 44.544

4.  CBL is frequently altered in lung cancers: its relationship to mutations in MET and EGFR tyrosine kinases.

Authors:  Yi-Hung Carol Tan; Soundararajan Krishnaswamy; Suvobroto Nandi; Rajani Kanteti; Sapana Vora; Kenan Onel; Rifat Hasina; Fang-Yi Lo; Essam El-Hashani; Gustavo Cervantes; Matthew Robinson; Han-Shui Hsu; Stephen C Kales; Stanley Lipkowitz; Theodore Karrison; Martin Sattler; Everett E Vokes; Yi-Ching Wang; Ravi Salgia
Journal:  PLoS One       Date:  2010-01-29       Impact factor: 3.240

5.  Somatic mutations of the Parkinson's disease-associated gene PARK2 in glioblastoma and other human malignancies.

Authors:  Selvaraju Veeriah; Barry S Taylor; Shasha Meng; Fang Fang; Emrullah Yilmaz; Igor Vivanco; Manickam Janakiraman; Nikolaus Schultz; Aphrothiti J Hanrahan; William Pao; Marc Ladanyi; Chris Sander; Adriana Heguy; Eric C Holland; Philip B Paty; Paul S Mischel; Linda Liau; Timothy F Cloughesy; Ingo K Mellinghoff; David B Solit; Timothy A Chan
Journal:  Nat Genet       Date:  2009-11-29       Impact factor: 38.330

6.  Deciphering associations for lung cancer risk through imputation and analysis of 12,316 cases and 16,831 controls.

Authors:  Yufei Wang; Yongyue Wei; Valerie Gaborieau; Jianxin Shi; Younghun Han; Maria N Timofeeva; Li Su; Yafang Li; Timothy Eisen; Christopher I Amos; Maria Teresa Landi; David C Christiani; James D McKay; Richard S Houlston
Journal:  Eur J Hum Genet       Date:  2015-03-25       Impact factor: 4.246

Review 7.  Comprehensive literature review and statistical considerations for GWAS meta-analysis.

Authors:  Ferdouse Begum; Debashis Ghosh; George C Tseng; Eleanor Feingold
Journal:  Nucleic Acids Res       Date:  2012-01-12       Impact factor: 16.971

8.  Epigenome-wide scans identify differentially methylated regions for age and age-related phenotypes in a healthy ageing population.

Authors:  Jordana T Bell; Pei-Chien Tsai; Tsun-Po Yang; Ruth Pidsley; James Nisbet; Daniel Glass; Massimo Mangino; Guangju Zhai; Feng Zhang; Ana Valdes; So-Youn Shin; Emma L Dempster; Robin M Murray; Elin Grundberg; Asa K Hedman; Alexandra Nica; Kerrin S Small; Emmanouil T Dermitzakis; Mark I McCarthy; Jonathan Mill; Tim D Spector; Panos Deloukas
Journal:  PLoS Genet       Date:  2012-04-19       Impact factor: 5.917

9.  Transcriptome and genome sequencing uncovers functional variation in humans.

Authors:  Tuuli Lappalainen; Michael Sammeth; Marc R Friedländer; Peter A C 't Hoen; Jean Monlong; Manuel A Rivas; Mar Gonzàlez-Porta; Natalja Kurbatova; Thasso Griebel; Pedro G Ferreira; Matthias Barann; Thomas Wieland; Liliana Greger; Maarten van Iterson; Jonas Almlöf; Paolo Ribeca; Irina Pulyakhina; Daniela Esser; Thomas Giger; Andrew Tikhonov; Marc Sultan; Gabrielle Bertier; Daniel G MacArthur; Monkol Lek; Esther Lizano; Henk P J Buermans; Ismael Padioleau; Thomas Schwarzmayr; Olof Karlberg; Halit Ongen; Helena Kilpinen; Sergi Beltran; Marta Gut; Katja Kahlem; Vyacheslav Amstislavskiy; Oliver Stegle; Matti Pirinen; Stephen B Montgomery; Peter Donnelly; Mark I McCarthy; Paul Flicek; Tim M Strom; Hans Lehrach; Stefan Schreiber; Ralf Sudbrak; Angel Carracedo; Stylianos E Antonarakis; Robert Häsler; Ann-Christine Syvänen; Gert-Jan van Ommen; Alvis Brazma; Thomas Meitinger; Philip Rosenstiel; Roderic Guigó; Ivo G Gut; Xavier Estivill; Emmanouil T Dermitzakis
Journal:  Nature       Date:  2013-09-15       Impact factor: 49.962

10.  Mutational landscape and significance across 12 major cancer types.

Authors:  Cyriac Kandoth; Michael D McLellan; Fabio Vandin; Kai Ye; Beifang Niu; Charles Lu; Mingchao Xie; Qunyuan Zhang; Joshua F McMichael; Matthew A Wyczalkowski; Mark D M Leiserson; Christopher A Miller; John S Welch; Matthew J Walter; Michael C Wendl; Timothy J Ley; Richard K Wilson; Benjamin J Raphael; Li Ding
Journal:  Nature       Date:  2013-10-17       Impact factor: 49.962

View more
  8 in total

1.  Potentially functional variants of HBEGF and ITPR3 in GnRH signaling pathway genes predict survival of non-small cell lung cancer patients.

Authors:  Yufeng Wu; Zhensheng Liu; Dongfang Tang; Hongliang Liu; Sheng Luo; Thomas E Stinchcombe; Carolyn Glass; Li Su; Lijuan Lin; David C Christiani; Qiming Wang; Qingyi Wei
Journal:  Transl Res       Date:  2021-01-02       Impact factor: 7.012

2.  Genetic variants of genes in the NER pathway associated with risk of breast cancer: A large-scale analysis of 14 published GWAS datasets in the DRIVE study.

Authors:  Jie Ge; Hongliang Liu; Danwen Qian; Xiaomeng Wang; Patricia G Moorman; Sheng Luo; Shelley Hwang; Qingyi Wei
Journal:  Int J Cancer       Date:  2019-05-13       Impact factor: 7.396

3.  Genetic variants in RUNX3, AMD1 and MSRA in the methionine metabolic pathway and survival in nonsmall cell lung cancer patients.

Authors:  Ka Chen; Hongliang Liu; Zhensheng Liu; Sheng Luo; Edward F Patz; Patricia G Moorman; Li Su; Sipeng Shen; David C Christiani; Qingyi Wei
Journal:  Int J Cancer       Date:  2019-02-01       Impact factor: 7.396

4.  Genetic variants in glutamine metabolic pathway genes predict cutaneous melanoma-specific survival.

Authors:  Ka Chen; Hongliang Liu; Zhensheng Liu; Wendy Bloomer; Christopher I Amos; Jeffrey E Lee; Xin Li; Hongmei Nan; Qingyi Wei
Journal:  Mol Carcinog       Date:  2019-08-22       Impact factor: 4.784

5.  Deciphering associations between three RNA splicing-related genetic variants and lung cancer risk.

Authors:  Wenjun Yang; Hongliang Liu; Ruoxin Zhang; Jennifer A Freedman; Younghun Han; Rayjean J Hung; Yonathan Brhane; John McLaughlin; Paul Brennan; Heike Bickeboeller; Albert Rosenberger; Richard S Houlston; Neil E Caporaso; Maria Teresa Landi; Irene Brueske; Angela Risch; David C Christiani; Christopher I Amos; Xiaoxin Chen; Steven R Patierno; Qingyi Wei
Journal:  NPJ Precis Oncol       Date:  2022-06-30

6.  Gene-based evaluation of low-frequency variation and genetically-predicted gene expression impacting risk of keloid formation.

Authors:  Jacklyn N Hellwege; Shirley B Russell; Scott M Williams; Todd L Edwards; Digna R Velez Edwards
Journal:  Ann Hum Genet       Date:  2018-02-27       Impact factor: 1.670

7.  Potentially Functional Variants of ATG16L2 Predict Radiation Pneumonitis and Outcomes in Patients with Non-Small Cell Lung Cancer after Definitive Radiotherapy.

Authors:  Juyi Wen; Hongliang Liu; Lili Wang; Xiaomeng Wang; Ning Gu; Zhensheng Liu; Ting Xu; Daniel R Gomez; Ritsuko Komaki; Zhongxing Liao; Qingyi Wei
Journal:  J Thorac Oncol       Date:  2018-02-15       Impact factor: 15.609

8.  Physical Activity and Glycemic Control Status in Chinese Patients with Type 2 Diabetes: A Secondary Analysis of a Randomized Controlled Trial.

Authors:  Wei-Yuan Yao; Meng-Ge Han; Giuseppe De Vito; Hong Fang; Qinghua Xia; Yingyao Chen; Xiaona Liu; Yan Wei; Russell L Rothman; Wang-Hong Xu
Journal:  Int J Environ Res Public Health       Date:  2021-04-18       Impact factor: 3.390

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.